BioNexus Gene Lab Corp Financial Overview
BioNexus Gene Lab Corp's market cap is currently $7.37M. The company's EPS TTM is $-0.888; its P/E ratio is -3.21; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.